Skip to content

Supracor LASIK for presbyopia

Supracor LASIK for Correction of presbyopia Efficacy and safety

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202505647818467
Enrollment
30
Registered
2025-05-15
Start date
2018-11-13
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Supracor LASIK

Sponsors

Azhar Assuit university
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Manifest refractive spherical equivalent (MRSE) of between +0.50 diopters (D) and +4.50 D, Mean keratometry readings from 41.0 to 45.0 dioptres, Age: 43 years or older, Central corneal thickness of 480µm or greater, Flap diameter more or equal 9ml, Pupil: Mesopic less than 6mm, Photopic more than 3mm, Corrected distance visual acuity (CDVA) of 20/40 or better, Optical zone size 6mm, Maximum difference between manifest and cycloplegic refraction +0.75 D .

Exclusion criteria

Exclusion criteria: The presence of ocular surface disease, Abnormal corneal topography, Patient with variable dilated pupil size, High style patients which need all vision task to be perfect 100%, Patient receive antidepressant or antiprostatic drugs, Age less than 43 years, Patient with high refractive errors more than + 4 in hypermetropia and astigmatism.

Design outcomes

Primary

MeasureTime frame
This study was conducted to assess the efficacy of supracor on near and distant vision.

Secondary

MeasureTime frame
This study was conducted to assess safety of supracor on near and distant vision.

Countries

Egypt

Contacts

Public ContactMahmoud Abdelbadie

Professor of ophthalmology

badie_eye@yahoo.com00201001472957

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026